Foley attorneys filed an amicus brief in the United States District Court for the Southern District of New York related to ACLU v. Myriad regarding subject matter patentability of gene patents specifically on isolated DNA. The authors conclude that the U.S. Congress, U.S. courts and the USPTO, as well as the scientific community and biotechnology industry have long relied upon an understanding that claims directed to “isolated DNA” recite patentable subject matter under 35 U.S.C. §101 and the Constitution. The authors maintain that to hold otherwise would have a dramatic negative effect on biotech research as we know it, and will influence the entire business of biotechnology in ways unforeseen or addressed by the plaintiffs in ACLU v. Myriad”
People
Related News
June 5, 2025
Press Releases
Foley Secures Top Rankings in Chambers USA 2025
Foley & Lardner LLP is proud to once again be recognized by Chambers & Partners as one of the leading law firms in the country in the 2025 edition of Chambers USA: America’s Leading Lawyers for Business.
June 2, 2025
Press Releases
Foley Opens Nashville Office with Addition of Three Corporate Partners
Foley & Lardner LLP announced today the opening of its newest office in Nashville, Tenn., with the addition of three corporate partners to support the firm’s growing Health Care & Life Sciences and Manufacturing Sectors.
May 22, 2025
Press Releases
Foley Continues Expansion in California with Two Corporate Partners in Silicon Valley
Foley & Lardner LLP announced today that it has expanded its Innovative Technology Sector and Transactions Practice Group with the addition of partners Gurpreet Bal and Shaalu Mehra to the firm’s Silicon Valley office. Both attorneys bring substantial experience advising technology companies, investors, and founders on complex transactional and corporate matters.